Drug repurposing in the era of COVID-19: a call for leadership and government investment

Jennifer H Martin; Nikola A Bowden

doi:10.5694/mja2.50603

Drug repurposing in the era of COVID-19: a call for leadership and government investment

Med J Aust. 2020 Jun;212(10):450-452.e1. doi: 10.5694/mja2.50603. Epub 2020 May 6.

Authors

Jennifer H Martin^{1

2}, Nikola A Bowden¹

Affiliations

¹ University of Newcastle, Newcastle, NSW.
² Hunter New England Health, Newcastle, NSW.

No abstract available

Keywords: COVID-19; Drug industry; Drugs, generic; Infectious diseases; Medicine, traditional; Policy, drugs and alcohol; Respiratory tract infections; Virology.

MeSH terms

Australia
Betacoronavirus
COVID-19
Coronavirus Infections / drug therapy*
Coronavirus Infections / virology
Drug Repositioning / economics*
Drug Repositioning / methods
Financing, Government*
Humans
Investments
Leadership
Pandemics
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / virology
SARS-CoV-2